Most Popular Stories
Webinars
- Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to MarketJoin us for a one-hour overview of the regulated clinical trials process used to bring a n
- Active Directory & the Cloud for Biotech & PharmaBiotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
Featured Jobs
-
Sr. Director, Alliance Management Job
Celgene Corporation - Summit, NJ, US -
Product Manager, Channel Marketing Job
Celgene Corporation - Summit, NJ, US -
Director Marketing Communications
Bailey Search & Associates - Boston, MA -
Clinical Research Associate
Jennerex, Inc - San Francisco, CA -
Manager, Business Development
Clinical Resource Network - Chicago, IL
Events
- CALBIO2012: Driven By Patients - Marriott Marquis
March 8-9 — San Francisco, CA - Live Web Conference: Risk Management of Adventitious Agent Contamination
March 21 - DCAT Week '12 Biologics Forum & Networking Reception
Mar 14 — New York City - Pharmaceutical Strategic Outlook
April 11-13, 2012
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 90,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- The FDA Review Process: a Technical Look
- The Top 10 Biotechnology Companies: Positioning, performance and SWOT analyses
- Online Multilingual marketing strategy
- Displacement Chromatography Comes of Age - An indispencable tool for the purification of biomacromolecules
- Failing to Establish and Maintain CAPA Systems? Your Company Could Be At Risk.
- cTQM (Clinical Total Quality Management)
Schering-Plough CEO Fred Hassan
